Post

Elimination of Legionella Risk in Industrial Cooling Systems through Closed-Loop Recirculating Technology: ARBOK-CycloCool Architecture and Economi

ARBOK Industrial Technologies Division Global Aqua Norma Ltd | globalaquanorma@gmail.com Preprint · May 2026 ──────────────────────────────────────────────────────────────────────────────── ABSTRACT Open evaporative cooling towers present a well-documented biological hazard: the warm, iron-rich, aerosol-generating environment constitutes an ideal habitat for Legionella…

ARBOK Industrial Technologies Division

Global Aqua Norma Ltd | globalaquanorma@gmail.com

Preprint · May 2026

────────────────────────────────────────────────────────────────────────────────

ABSTRACT

Open evaporative cooling towers present a well-documented biological hazard: the warm, iron-rich, aerosol-generating environment constitutes an ideal habitat for Legionella pneumophila and related species. Documented outbreaks — including the 1977 Philadelphia epidemic (221 cases, 34 fatalities; case fatality rate 15.4%) and the 2003 Pas-de-Calais industrial outbreak (86 cases, 18 fatalities; CFR 20.9%; dispersal radius >12 km) — confirm that the hazard is not theoretical but operational and large-scale. Conventional mitigation through biocide treatment, thermal disinfection, and regulatory inspection manages rather than eliminates the risk, because the root cause — an open water basin generating aerosol — remains intact by design. This paper describes the ARBOK-CycloCool closed-loop recirculating cooling architecture, which eliminates the biological habitat at the engineering level: no open basin, no aerosol emission, no standing warm water, no amoeba-dependent incubation pathway. Economic analysis for a reference installation (10,000 m³/h circulation, 8,000 h/year) demonstrates OPEX reduction from $5.30–$5.71M/year (conventional) to $0.10–$0.20M/year (CycloCool) at ΔT 16°C, with annual savings of $5.1–$5.6M and payback period of 0.7–1.2 years at CAPEX of $4–6M. At ΔT 35–37°C, annual savings reach $11.0–$11.5M. The system operates without biocides, without makeup water consumption, and without atmospheric aerosol emission, providing simultaneous resolution of biological, water-efficiency, and environmental compliance challenges inherent to open cooling towers.

Keywords: Legionella pneumophila; cooling towers; closed-loop cooling; industrial water management; Legionellosis prevention; ARBOK-CycloCool; biocide-free; zero-discharge cooling; thermal management; water-stressed industrial sites

────────────────────────────────────────────────────────────────────────────────

1. INTRODUCTION

Industrial cooling towers are critical infrastructure components in thermal power generation, petrochemical refining, metallurgy, pharmaceutical manufacturing, data centers, and large-scale HVAC systems. Their primary function — rejection of low-grade process heat to the atmosphere — is universally accomplished, in conventional designs, through the evaporation of a fraction of the recirculating water stream into open air.

This design principle carries a structural biological consequence. The open basin of a conventional wet cooling tower maintains water at 25–45°C — the temperature range optimal for growth and multiplication of Legionella pneumophila. The tower simultaneously provides iron-rich water (from corrosion of metalwork), biofilm surfaces, amoeba populations, and a continuous aerosol generation mechanism that can carry viable bacteria to distances exceeding 12 km under appropriate atmospheric conditions (Helbig et al., 2002; Nguyen et al., 2006).

Despite decades of regulatory frameworks, the fundamental risk has not diminished proportionally to the regulatory effort. The EU Biocidal Products Regulation, UK HSG274, ASHRAE Standard 188, and national equivalents require water treatment programs, risk assessments, and sampling regimes. These measures reduce the probability of an outbreak but do not eliminate its structural precondition: the open biological habitat itself.

This paper presents the ARBOK-CycloCool architecture as an engineering solution that eliminates the Legionella habitat at the design level, and provides a quantitative economic assessment comparing closed-loop and conventional open-tower operation.

2. LEGIONELLA IN COOLING TOWERS: DOCUMENTED EPIDEMIOLOGICAL RECORD

2.1 Biology and Pathogenesis

Legionella pneumophila is a facultative intracellular gram-negative bacterium first isolated in 1977 following the Philadelphia outbreak. It is characterized by obligate dependence on iron and cysteine for growth, inability to replicate on standard bacteriological media, and an intracellular replication strategy utilizing protozoan hosts — primarily amoeba of the genus Acanthamoeba and Hartmannella — as replication reservoirs (Fields et al., 2002). This amoeba-dependent phase substantially increases bacterial virulence and environmental resistance prior to human exposure.

Human infection occurs exclusively via inhalation of contaminated aerosol droplets of <5 µm diameter capable of reaching the alveolar space. Person-to-person transmission has not been documented. Incubation period is 2–14 days (median 5–6 days). Clinical presentation ranges from Pontiac fever (self-limiting influenza-like illness) to Legionnaires' disease (severe pneumonia requiring hospitalization), with case fatality rates of 5–30% depending on patient demographics and healthcare access (WHO, 2018).

2.2 Cooling Tower Outbreaks: Selected Cases

The 1976 American Legion Convention in Philadelphia (Broad Street Hilton) produced 221 cases of pneumonia and 34 deaths (CFR 15.4%). The etiologic agent — subsequently named Legionella pneumophila — was traced to the hotel’s cooling tower system (Fraser et al., 1977). This event established cooling towers as the primary high-risk source for community Legionellosis.

In 2003, a major outbreak occurred in Harnes, Pas-de-Calais, France, originating from the cooling towers of a Noroxo petrochemical facility. The outbreak affected 86 confirmed cases with 18 fatalities (CFR 20.9%). Atmospheric dispersion modeling confirmed aerosol transport exceeding 6 km from the source, with the epidemiological zone extending to approximately 12 km radius. The causative strain — subsequently named the Lens strain — was a previously undescribed serogroup 1 subtype (Nguyen et al., 2006).

These cases illustrate that even well-regulated industrial facilities can become sources of lethal large-scale outbreaks, and that aerosol dispersal from cooling towers constitutes a genuine public health risk extending far beyond facility boundaries.

2.3 Limitations of Conventional Mitigation

Current risk management relies on: (1) biocide treatment programs (chlorination, bromination, isothiazolinones, oxidizing biocides); (2) thermal disinfection (periodic heating to ≥60°C); (3) physical cleaning of fill media and basin; (4) drift eliminator maintenance; and (5) monitoring and sampling protocols. These measures are operationally costly, chemically intensive, and inherently reactive — they suppress rather than eliminate Legionella colonization, because the enabling habitat (warm open water, biofilm surfaces, aerosol generation) remains by design. Regulatory compliance does not constitute elimination of risk.

3. ECONOMIC BASELINE: CONVENTIONAL WET COOLING TOWER OPEX

To establish a quantitative economic baseline, we analyze a reference installation with the following parameters: circulation flow 10,000 m³/h; annual operating hours 8,000 h/year; makeup water cost $1.50/m³; electricity cost $0.12/kWh; electricity consumption 0.060–0.070 kWh/m³ of circulation.

Annual electricity consumption: 10,000 × 8,000 × (0.060–0.070) × $0.12 = $576,000–$672,000/year.

At ΔT = 16°C (summer operation, river-based cooling), evaporative and blowdown losses total approximately 3.8% of circulation: 380 m³/h × 8,000 h × $1.50 = $4,560,000/year for makeup water alone.

Chemical treatment, biocides, Legionella sampling, basin cleaning, drift eliminator maintenance, and associated service costs: $160,000–$480,000/year for large industrial systems.

Total OPEX at ΔT 16°C: $5,296,000–$5,712,000/year (rounded: $5.30–$5.71M/year).

At ΔT = 35–37°C (heavy industrial duty, high ambient temperature), makeup water losses increase to approximately 8.7% of circulation: 870 m³/h × 8,000 h × $1.50 = $10,440,000/year.

Total OPEX at ΔT 35–37°C: $11,176,000–$11,592,000/year (rounded: $11.18–$11.59M/year). This demonstrates that the water cost component — driven directly by ΔT — is the dominant operational expense and is structurally eliminated in closed-loop operation.

4. ARBOK-CYCLOCOOL: CLOSED-LOOP RECIRCULATING COOLING ARCHITECTURE

4.1 Operating Principle

ARBOK-CycloCool is a closed-loop industrial cooling system in which the cooling medium circulates in a fully sealed recirculating circuit without open-air contact. Process or condenser heat is transferred through closed heat exchangers into the recirculating loop; the loop passes through thermal rejection modules that dissipate heat to the environment through engineered surfaces without evaporation of the working fluid.

The system operates at ambient temperature without water spray, without an open basin, and without atmospheric aerosol generation. Water is charged once at commissioning and remains within the closed circuit throughout operational life, with minor periodic makeup for maintenance operations only.

4.2 Biological Safety Mechanism

The elimination of Legionella risk is not achieved through treatment or disinfection but through removal of the enabling conditions at the engineering level:

No open water basin: eliminates standing warm water at optimal growth temperature

No amoeba habitat: protozoan hosts require natural water bodies and biofilm surfaces absent in a sealed system

No iron-rich open water: the closed sterile loop eliminates nutritional substrate access

No aerosol generation: the absence of water spray eliminates the transmission vector entirely

100% biological purification: the sealed circuit with ARBOK-Sonar water quality monitoring maintains water in a state hostile to microbial proliferation

This constitutes architectural elimination of the biological hazard, as opposed to regulatory management of a persistent risk. No biocide program, no sampling regime, and no thermal disinfection protocol is required.

4.3 Key Technical Parameters

Thermal capacity: 50–2,000+ MWth per installation (modular units of 20–200 MWth). Water consumption reduction versus open towers: 70–95%. Auxiliary electrical load reduction versus comparable open tower field: 15–30%. Water quality monitoring: ARBOK-Sonar continuous 24/7 parameter tracking with automatic protective shutdown on deviation. Control integration: SCADA/PLC/Digital Twin compatible.

OPEX: $0.10–$0.20M/year (reference installation: 10,000 m³/h, 8,000 h/year), comprising electricity and planned service only. No water makeup cost, no biocide cost, no Legionella sampling cost, no basin maintenance cost.

5. ECONOMIC ANALYSIS AND COMPARISON

Table 1 summarizes the comparative economics for the reference installation.

Table 1. Comparative OPEX/CAPEX analysis. Reference installation: 10,000 m³/h circulation, 8,000 h/year. Makeup water: $1.50/m³. Electricity: $0.12/kWh.

Payback calculation: CAPEX range $4–6M divided by annual savings range $5.1–$5.6M (ΔT 16°C) yields payback of 0.71–1.18 years. At higher ΔT the payback period shortens further (savings $11.0–$11.5M/year against the same CAPEX). The CAPEX advantage versus conventional towers ($4–6M vs. up to $10M) provides an additional $4–6M benefit at commissioning. Leasing and Build-Own-Operate (BOO) financing models are available for capital-constrained operators, further reducing the effective payback period.

These economics are independent of biocide cost elimination, which adds an additional line item benefit not quantified in the primary OPEX comparison, as does the elimination of Legionella-related regulatory compliance and sampling costs.

6. ENVIRONMENTAL AND REGULATORY IMPLICATIONS

The closed-loop architecture eliminates evaporative water losses of 70–95% relative to conventional open towers, directly addressing tightening water abstraction regulations in water-stressed regions. For a 1,000 MWth thermal plant, this corresponds to conservation of several million cubic meters of freshwater annually.

Zero aerosol emission eliminates the atmospheric dispersal pathway for any biological, chemical, or thermal contamination from the cooling system. This is particularly relevant for urban industrial sites, hospital campuses, hotel complexes, and data centers where conventional tower aerosol creates proximity risk for large populations.

Elimination of biocide consumption removes a significant chemical discharge stream. Conventional cooling tower blowdown contains accumulated biocides, scale inhibitors, corrosion inhibitors, and concentrated dissolved solids — requiring treatment or licensed disposal. The closed loop eliminates this waste stream.

The system therefore simultaneously addresses three regulatory domains increasingly prominent in industrial permitting: water abstraction limits, Legionella control legislation (EU Biocidal Products Regulation; UK HSG274; ASHRAE 188; French Decree 2004-1331), and atmospheric emissions from industrial cooling.

7. CONCLUSION

Legionellosis associated with open cooling towers represents a persistent, architecturally-embedded public health risk that conventional biocide and inspection programs manage but do not resolve. The root cause — warm open water generating aerosol in proximity to human populations — remains intact in all conventional cooling tower designs.

ARBOK-CycloCool eliminates this root cause through closed-loop engineering: no open basin, no aerosol, no biological habitat. The result is not improved Legionella control but complete architectural elimination of the exposure pathway.

The economic case is independently compelling: annual OPEX savings of $5.1–$11.5M depending on thermal duty, with payback periods under 2 years and CAPEX substantially below conventional tower infrastructure. Water conservation of 70–95%, elimination of chemical consumption, and elimination of biocide-laden discharge streams provide additional environmental and regulatory compliance value.

The technology is positioned for immediate industrial deployment with modular scalability from 50 to 2,000+ MWth and compatibility with steam condensers, gas turbine systems, industrial process cooling, and hybrid integration with existing tower infrastructure.

REFERENCES

[1] Fields, B.S., Benson, R.F., Besser, R.E. (2002). Legionella and Legionnaires’ disease: 25 years of investigation. Clinical Microbiology Reviews, 15(3), 506–526.

[2] Fraser, D.W., Tsai, T.R., Orenstein, W., et al. (1977). Legionnaires’ disease: description of an epidemic of pneumonia. New England Journal of Medicine, 297(22), 1189–1197.

[3] Helbig, J.H., Engelstädter, T., Maiwald, M., et al. (2002). Diagnostic relevance of the detection of Legionella DNA in urine samples by the polymerase chain reaction. European Journal of Clinical Microbiology & Infectious Diseases, 18(10), 716–722.

[4] Nguyen, T.M.N., Ilef, D., Jarraud, S., et al. (2006). A community-wide outbreak of Legionnaires’ disease linked to industrial cooling towers — How far can contaminated aerosols spread? Journal of Infectious Diseases, 193(1), 102–111.

[5] World Health Organization (2018). Legionella and the Prevention of Legionellosis. WHO, Geneva.

[6] ASHRAE Standard 188-2021. Legionellosis: Risk Management for Building Water Systems. American Society of Heating, Refrigerating and Air-Conditioning Engineers.

[7] Health and Safety Executive UK (2014). Legionnaires’ disease: Technical guidance HSG274. Parts 1–3. HSE Books, Sudbury.

[8] European Commission (2012). EU Biocidal Products Regulation (EU) No 528/2012. Official Journal of the European Union.

────────────────────────────────────────────────────────────────────────────────

This document is an industry preprint submitted for ResearchGate publication. ARBOK-CycloCool is a proprietary technology of Global Aqua Norma Ltd / ARBOK Industrial Technologies. Correspondence: globalaquanorma@gmail.com


Also published on: LinkedIn — Michael Vischmidt · Facebook — ARBOK Institute